Michael R Hayden, Director, on July 30, 2026, executed a purchase for 20,000 shares in Ionis Pharmaceuticals (IONS) for $1,058,700. Following the Form 4 filing with the SEC, Hayden has control over a total of 78,298 common shares of the company, with 54,298 shares held directly and 24,000 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/874015/000087401526000254/xslF345X05/edgardoc.xml
Darren Zeidel, General Counsel, on July 28, 2026, sold 1,900 shares in Aon (AON) for $717,750. Following the Form 4 filing with the SEC, Zeidel has control over a total of 11,504 Class A ordinary shares of the company, with 11,504 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/315293/000119312526326365/xslF345X05/ownership.xml
Grigorios Zikos, Director, Chief Financial Officer, on July 29, 2026, sold 59,840 shares in Costamare (CMRE) for $917,916.SEC Filing:https://www.sec.gov/Archives/edgar/data/1503584/000150358426000010/xslF345X05/form4.xml
Walter Stanley Berman, Executive Vice President and CFO, on July 28, 2026, sold 11,012 shares in Ameriprise Financial (AMP) for $6,045,030. Following the Form 4 filing with the SEC, Berman has control over a total of 5,976 common shares of the company, with 5,609 shares held directly and 367 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/820027/000133576126000013/xslF345X05/form4-07302026_090743.xml